TherapeuticsMD Announces FDA Approval BIJUVA for Moderate to Severe Hot Flashes Due to Menopause

The FDA has just approved BIJUVA, an oral hormone therapy for moderate to severe vasomotor symptoms (also known as hot flashes) due to menopause. This is the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single capsule.​Menopause is a naturally occurring transition for women with an average onset age … Read more